On Friday, August 10, a San Francisco jury ordered Monsanto to pay $289 million to Dewayne Johnson, who developed non-Hodgkin’s lymphoma after using Roundup in his job as school groundskeeper. After two days of deliberations, the jury found that Monsanto, a unit of the pharmaceutical company Bayer AG following a $62.5 billion acquisition, was at least partly liable for causing Johnson’s terminal cancer. Johnson’s case, claiming that glyphosate, the principal chemical in Monsanto’s Roundup, caused his cancer, was one of...Continue Reading
Consumption of Spring Pasta Salad has been linked to Salmonella If you or a loved one ate Spring Pasta Salad from a Hy-Vee store before July 17 and suffered an illness after eating it, you may be entitled to compensation for those injuries. Contact a lawyer today for a free and confidential legal consultation. Free Case Evaluation TOLL FREE 1 (888) 402-5552 The Minnesota Department of Health has issued a news release linking recent cases of Salmonella Sandiego with consumption...Continue Reading
Trial began Wednesday in a case where twenty-two women have accused Johnson & Johnson of failing to protect consumers. The pharmaceutical and consumer goods company faces claims that it knew that its Baby Powder, Shower to Shower and other talc-based products contained asbestos and failed to warn consumers. Plaintiffs allege that the asbestos-contaminated talc caused their ovarian cancer. Johnson & Johnson says that its talc products have not and do not contain asbestos and that their products do not cause...Continue Reading
Opening arguments began this week in the first bellwether trial in a consolidated action against 3M’s Bair Hugger line of products. An attorney for Louis Gareis, a South Carolina hip replacement patient, argued in federal court that the Bair Hugger blanket was defectively designed, causing an increased risk of infection in surgery patients. 3M’s Bair Hugger products are forced-air warming blankets used to stabilize a surgery patient’s body temperature before, during and after surgery. These blankets are used in more...Continue Reading
The first trial resulting from an Invokana injury lawsuit in New Jersey is reportedly slated for September 2018 as the number of lawsuits filed in the District of New Jersey continues to increase. What Exactly is Invokana? Invokana (also referred to as “Canagliflozin”) made headlines when the U.S. Food and Drug Administration approved it in 2013 as a revolutionary drug for treating Type 2 diabetes. In addition to blocking the kidneys from absorbing glucose, it’s formulated as an effective SGLT2...Continue Reading
Speak with a Lawyer
Contact an attorney today for a free and confidential legal consultation.